WO2000052468A1 - Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer - Google Patents
Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer Download PDFInfo
- Publication number
- WO2000052468A1 WO2000052468A1 PCT/US2000/005509 US0005509W WO0052468A1 WO 2000052468 A1 WO2000052468 A1 WO 2000052468A1 US 0005509 W US0005509 W US 0005509W WO 0052468 A1 WO0052468 A1 WO 0052468A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- absorbent layer
- air gap
- sample
- layer
- glucose
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2575—Volumetric liquid transfer
Definitions
- the present invention relates to analyzing liquid samples and more specifically to controlling the absorption of a liquid sample by an absorbent layer, thereby reducing the effect of hematocrit.
- Test strips are widely available for conveniently analyzing liquid samples.
- a test strip has one or more layers of absorbent material containing chemical reagents.
- the reagents react with the components of interest in the test sample.
- the resulting reaction can then be measured by a variety of means to yield a measurement of the components in the sample .
- a glucose test strip can have an absorbent layer containing reagents that react with glucose present in the blood sample.
- the reagents react with the glucose in the sample. If the reaction results in a detectable color change -- turning the absorbent layer from colorless to dark blue, for example -- the reaction can then be measured, and the amount of color produced related to the concentration of glucose in the blood sample .
- a patient will typically use the test strip with a separate device that can measure the chemical reaction on the absorbent layer and display the patient's blood glucose concentration.
- a separate device that can measure the chemical reaction on the absorbent layer and display the patient's blood glucose concentration.
- One such device uses a reflectance meter, which measures reflected light of specific wavelengths, to monitor the light reflected from the surface of the absorbent layer.
- the reflectance meter can monitor the reaction by detecting changes in the light reflected from the surface of the absorbent layer. For example, as the chemical reaction proceeds, the reflectance meter can measure an increase of blue light reflected from the absorbent layer surface.
- the reflectance of light from the absorbent layer can be used to monitor the chemical reaction and thereby determine the glucose concentration in the blood sample.
- a second variable that can affect the test results is the hematocrit of the patient's blood, which is a measure of the relative amount of red blood cells and plasma in a blood sample. Because the hematocrit of a patient's blood sample can vary, the absorption of the sample by the absorbent layer can vary as well, resulting in hematocrit-dependent measurements of the patient's blood glucose concentration.
- the present invention provides a method for controlling the absorption of a liquid sample through an absorbent layer 2 by (a) providing an air gap 4c defined by the absorbent layer 2, at least one side wall 4d and a translucent window 6; and (b) applying the liquid sample to the absorbent layer on the side opposite to the air gap 2a.
- the sample absorption is controlled by preventing the release of air from the air gap 4c.
- the present invention also provides an apparatus for performing the method of the invention.
- the apparatus has an absorbent layer 2, at least one side wall 4d and a translucent window 6, where the layer, walls and window define an air gap 4c.
- Figure 1 shows an isometric view of one embodiment of the apparatus (not to scale) .
- Figure 2 shows a cross-sectional view of one embodiment of the apparatus (not to scale) .
- the plane of the cross-section is indicated in Figure 1.
- Figure 3 shows an exploded isometric view of another embodiment of the apparatus including optional elements (not to scale) .
- Second layer (optional)
- Figure 4 compares the relative volume- dependence of test strip Model A (with air gap) and Model B (without air gap) .
- Figure 5 compares the relative hematocrit- dependence of test strip Models A and B. DETAILED DESCRIPTION OF THE INVENTION
- the present invention provides a method and apparatus for controlling the absorption of a liquid sample by an absorbent layer.
- a liquid sample is applied to the application surface 2a of the absorbent layer 2, the sample is absorbed.
- an air gap 4c is provided, defined by the viewing surface 2b on the opposite side of the absorbent layer 2, at least one side wall 4d and a surface of a translucent window 6a.
- the "air gap” thus defined is an air-tight chamber with ambient air pressure .
- Absorption of the liquid sample causes a slight increase in pressure within the air gap compared with the ambient pressure. This pressure increase can be explained by the decrease in effective volume of the air gap as the liquid absorbed by the layer displaces air within the layer. Because the air gap lacks an exit for the displaced air to escape, the air gap effectively prevents further sample from being absorbed by the absorbent layer.
- Liquid samples that can be used with the invention encompass any fluid containing an analyte to be measured, for example blood, serum or plasma.
- the term also encompasses other "human body fluids” such as sweat, tears, saliva, semen, cerebrospinal fluid, sputum, urine and cervical mucus or swabbings .
- the term further encompasses food, environmental or industrial samples, depending on the desired application of the article, as long as they are liquid and contain an analyte for measurement.
- the liquid sample can be analyzed for specific "analytes" of interest, which are any substances to be detected or quantitated in terms of concentration.
- the analyte can be glucose, fructose, or other sugars, cholesterol, ketones, lipids, uric acid or specific amino acids such as phenylalanine .
- the analyte can also be proteins, for example enzymes such as amylase, creatine kinase or alanine aminotransferase .
- analyte can be glycated proteins, for example serum or plasma glycated protein as measured by fructosa ine, or red blood cell glycated protein as measured by glycated hemoglobin, in particular Hb Alc .
- glycated proteins for example serum or plasma glycated protein as measured by fructosa ine, or red blood cell glycated protein as measured by glycated hemoglobin, in particular Hb Alc .
- Other analytes are described in U.S. Patent No. 5,597,532, incorporated herein by reference.
- the "absorbent layer” can be any material that is permeable to gas when dry and can absorb liquid, but is relatively less permeable to gas when saturated or partially saturated with liquid.
- a particular absorbent layer is BIODYNE A 0.65 ⁇ m pore size nylon membrane (Pall Corp.; East Hills, New York).
- the absorbent layer can contain a reagent that indicates the presence of an analyte such as glucose or fructosamine .
- Representative absorbent layers are described in U.S. Patent No. 5,470,752, U.S. Patent No. 5,597,532 and U.S. Patent No. 5,695,949, each incorporated herein by reference.
- a particularly useful absorbent layer contains a reagent that reacts with glucose in the liquid sample, for example a glucose oxidase/horseradish peroxidase system (Toyobo Inc.; Tokyo, Japan).
- a glucose oxidase/horseradish peroxidase system Toyobo Inc.; Tokyo, Japan.
- Another useful system for reacting with glucose is N-ethyl-N-2-hydroxy- 3-sulfopropyl-3, 5-dimethylaniline (MAOS) (Dojindo Laboratories; Kumamoto, Japan) and N-ethyl-N- (2-hydroxy- 3-sulfopropyl) -m-toluidine (TOOS).
- MAOS 5-dimethylaniline
- TOOS N-ethyl-N- (2-hydroxy- 3-sulfopropyl) -m-toluidine
- reagents include the combination of 4-aminoantipyrene and chromotropic acid (AAP-CTA) and the combination of 3- methyl-2-benzothiazoline hydrazone hydrochloride (MBTH) and either 3-dimethylaminobenzoic acid (DMAB) or 8-anilo- 1-napthalenesulfonate (ANS) .
- AAP-CTA 4-aminoantipyrene and chromotropic acid
- MBTH 3- methyl-2-benzothiazoline hydrazone hydrochloride
- DMAB 3-dimethylaminobenzoic acid
- ANS 8-anilo- 1-napthalenesulfonate
- the absorbent layer can be attached to a handle 4 so the user to hold the test strip without touching the absorbent layer.
- the handle contains a hole 4c, whose inner walls 4d partially define the air gap.
- Figure 3 shows that the side wall 4d is the inner surface of a hole 4c.
- hole 4c is circular in Figure 3, it can also be of any shape so that there can be two or more distinct side walls forming the air gap.
- the handle 4 can be attached to the absorbent layer 2 by any means for adhering two layers together so long as the resulting air gap is secure against the escape of air and does not occlude the viewing surface of the absorbent layer 2b along the line of sight 7.
- the means for adhering can be acrylic-, rubber- or silicone-based adhesives.
- a particularly useful acrylic-based adhesive layer is FAS-TAPE 8311 double- coated acrylic-based adhesive (Avery-Dennison, Inc.; Pasadena, California) .
- Other adhesives include 3M 444 or 3M 415 double-coated adhesives (3M; Minneapolis, Minnesota) .
- Means for adhering the sintered polymer to the solid can also include PVC plastic pipe cement, epoxy, heat staking, clamping, bolting, nailing, compression fitting and immobilization by vacuum.
- the test strip also has a translucent window 6, which partially defines the air gap 4c by one of its surfaces 6a.
- the "translucent window” should allow light to travel substantially along line of sight 7 to pass through the window 6 and reach the viewing surface 2b and be reflected back through window 6 so that the reflected light can be detected.
- the window 6 may be treated to be "non-fogging" so that temperature differences in the window do not result in condensation of moisture from the ambient atmosphere.
- the window 6 can be attached to the handle 4 by any of the means for adhering two layers discussed above.
- an adhesive layer 3 can be used to attach the absorbent layer 2 to the handle 4, and another adhesive layer 5 can be used to attach the handle 4 to the window 6.
- the adhesive layers 3 and 5 should have holes 3c and 5c so that they do not interfere with line of sight 7.
- the air gap will then be defined by the viewing surface of the absorbent layer 2b, by the inner side walls of the adhesive layer 3d, of the handle 4d and of the second adhesive layer 5d, and by the surface of the window 6a.
- Additional layers can be added to the apparatus, for example a second layer 1 for separating a whole blood sample and allowing blood plasma to reach the application surface of absorbent layer 2a.
- a second layer 1 for separating a whole blood sample and allowing blood plasma to reach the application surface of absorbent layer 2a.
- Such layers are well known in the art and are exemplified by the whole blood separation layers in U.S. Patent No. 5,725,774, which is incorporated by reference.
- Model A with the air gap Model A with the air gap
- Models B and C without an air gap Each of the models had a solid polyester handle 4 and an absorbent layer 2, which was BIODYNE A 0.65 ⁇ m pore size nylon membrane (Pall Corp.; East Hills, New York).
- the absorbent layer was impregnated with a glucose oxidase/horseradish peroxidase system (Toyobo Inc.; Tokyo, Japan) and MAOS (N-ethyl-N-2-hydroxy-3-sulfopropyl-3, 5-dimethylaniline, sodium salt, monohydrate) (Dojindo Laboratories; Kumamoto, Japan) .
- the handle 4 and absorbent layer 2 were attached with an adhesive layer 3, which was FAS- TAPE 8311 double-coated acrylic-based adhesive (Avery- Dennison, Inc.; Pasadena, California). These common features were modified in the three models as follows. Model A, which featured the air gap, also had a translucent window 6 of MYLAR D 4 mil-thick transparent polyester film (Dupont & Co.; Wilmington, Delaware). The film was treated by dipping in PERFECT VIEW non-aerosol anti-fog lens cleaner (Tyr Sport Inc.; Huntington Beach, California) . The film was attached to the handle 4 by an adhesive layer 5, which was the same as adhesive layer 3 above.
- a second layer 1 was T667 or 6664 spunbonded white polyester fabric (Reemay, Inc.; Old Hickory, Tennessee) .
- the second layer was treated with between 0.0001% and 0.1% PLURONIC polyoxypropylene polyoxyethylene block copolymer (Pragmatics Inc.; Oak Ridge, Tennessee), 8% mannitol, and 0.15% hexadimethrin, all in a 0.85% NaCl solution.
- Model B had a second layer 1 of hydrophillic 0.0635 cm thick POREX XM-1342 sintered high density polyethylene (HDPE) treated as described for second layer 1 in Model A.
- the layer was further treated as described in U.S. Patent Application Ser. No. 09/006,787, filed January 14, 1998.
- Model C had a second layer 1 of T667 or 6664 spunbonded white polyester fabric (Reemay, Inc.; Old Hickory, Tennessee) .
- the second layer was treated as described for second layer 1 in Model A.
- EDTA tripotassium ethylenediaminetetraacetate
- the sample was then applied to a test strip when inserted into a device containing a reflectance meter.
- a light-emitting diode (LED) in the device directed light having a wavelength of 635 nm to the viewing surface of the absorbent layer 2b essentially along line of sight 7.
- the reflectance of the viewing surface 2b was measured by the reflectance meter over time using a silicon photodiode, which generated an analog signal.
- the signal was then processed by a transconductance amplifier, a synchronous detector, an analog-to-digital converter and a microprocessor. Automated processing and analysis of such detector signals is well known in the field of medical devices (see, for example, U.S. Patent 5,597,532).
- the microprocessor then displayed the calculated values for the concentration of glucose based on a standard curve using samples having known glucose concentrations.
- test strips featuring an air gap provide more consistent measurements than models without an air gap.
- Model A which features the air gap
- Models B and C which do not feature an air gap
- the measured glucose concentration may vary, depending on the volume of the sample applied to the strip, because of wet-through.
- the following example shows that the measurements from test strips with an air gap are less subject to variation due to changes in the volume of the sample.
- Blood samples were prepared at about 100, 300 and 500 mg/dL as described in Example III. Samples of 3.5, 4, 5, 10, 15, 20, 30 and 40 ⁇ L of each concentration were applied to 4 strips each of models A and B, and measured using the device described in Example II.
- Figure 4 show the average measured glucose concentrations (y-axis) using models A (three sets of solid lines) and B (three sets of dotted lines) for varying sample volumes (x-axis) and varying actual glucose concentrations (upper, middle and lower pairs of solid and dotted lines) . It is apparent that measured glucose concentrations for Model A, with the air gap, is more consistent across a range of sample volumes from 4 ⁇ l to 40 ⁇ l . In contrast, the measurements from Model B are only somewhat consistent between 10 ⁇ l and 40 ⁇ l .
- Model A which has an air gap
- Measurements of glucose concentration can also vary depending on the hematocrit, which is a measure of the relative amounts of red blood cells and plasma in a blood sample.
- hematocrit is a measure of the relative amounts of red blood cells and plasma in a blood sample. The following example shows that the results from test strips with an air gap are less likely to be affected by the hematocrit of the blood sample than test strips without an air gap.
- Blood samples were prepared at about 100, 200 and 400 mg/dL as described in Example III with hematocrits of 0 (plasma), 20, 30, 40, 50, 60 and 80%, where 80% represents the hematocrit of a sample when it is spun at 5000 rpm for 30 minutes and all plasma is removed. Sample volumes of 15 ⁇ l were applied to each of 8 strips of Models A and B each, using the device described in Example II.
- Model A yields relatively consistent glucose measurements over the range of hematocrit values.
- Model B can yield misleadingly low measurements as the hematocrit increases, especially when the sample contains high concentrations of glucose.
- Model A which features the air gap
- Model B which lacks an air gap
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00917704A EP1159613B1 (en) | 1999-03-03 | 2000-03-02 | Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer |
AT00917704T ATE307337T1 (en) | 1999-03-03 | 2000-03-02 | METHOD AND DEVICE FOR CONTROLLING LIQUID SAMPLES ABSORPTION THROUGH AN ABSORBING LAYER |
DK00917704T DK1159613T3 (en) | 1999-03-03 | 2000-03-02 | Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer |
DE60023270T DE60023270T2 (en) | 1999-03-03 | 2000-03-02 | Method and apparatus for controlling the absorption of a liquid sample through an absorbent layer |
AU38636/00A AU3863600A (en) | 1999-03-03 | 2000-03-02 | Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer |
HK02104286.3A HK1042943B (en) | 1999-03-03 | 2002-06-05 | Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/261,707 | 1999-03-03 | ||
US09/261,707 US6656741B1 (en) | 1999-03-03 | 1999-03-03 | Air gap for controlling sample absorption and hematocrit dependence |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000052468A1 true WO2000052468A1 (en) | 2000-09-08 |
Family
ID=22994512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/005509 WO2000052468A1 (en) | 1999-03-03 | 2000-03-02 | Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer |
Country Status (9)
Country | Link |
---|---|
US (1) | US6656741B1 (en) |
EP (1) | EP1159613B1 (en) |
AT (1) | ATE307337T1 (en) |
AU (1) | AU3863600A (en) |
DE (1) | DE60023270T2 (en) |
DK (1) | DK1159613T3 (en) |
ES (1) | ES2251368T3 (en) |
HK (1) | HK1042943B (en) |
WO (1) | WO2000052468A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6656741B1 (en) | 1999-03-03 | 2003-12-02 | Diabetes Diagnostics, Inc. | Air gap for controlling sample absorption and hematocrit dependence |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2426246A1 (en) * | 2000-10-18 | 2002-04-25 | Clarity Technologies Incorporated | Method and device for diluting a fluid and detecting analytes within a diluted fluid |
WO2009076302A1 (en) | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Control markers for auto-detection of control solution and methods of use |
EP2496941B1 (en) | 2009-11-04 | 2016-07-13 | Thomas M. Buchanan | Methods and devices to enhance sensitivity and evaluate sample adequacy and reagent reactivity in rapid lateral flow immunoassays |
US9476875B2 (en) | 2015-03-02 | 2016-10-25 | Chembio Diagnostic Systems, Inc. | Integrated buffer dual-path immunoassay device |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0215419A2 (en) * | 1985-09-18 | 1987-03-25 | Miles Inc. | Volume metering capillary gap device for applying a liquid sample onto a reactive surface |
US5470752A (en) * | 1994-06-29 | 1995-11-28 | Lxn Corporation | Multi-layer devices and methods of assaying for fructosamine |
US5597532A (en) * | 1994-10-20 | 1997-01-28 | Connolly; James | Apparatus for determining substances contained in a body fluid |
US5695949A (en) * | 1995-04-07 | 1997-12-09 | Lxn Corp. | Combined assay for current glucose level and intermediate or long-term glycemic control |
US6024919A (en) * | 1998-01-14 | 2000-02-15 | Lxn Corporation | Sonic treatment to selectively reduce the void volume of sintered polymers |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA733612B (en) | 1972-10-11 | 1974-04-24 | Merck Patent Gmbh | Container for test strips |
US3992158A (en) * | 1973-08-16 | 1976-11-16 | Eastman Kodak Company | Integral analytical element |
US4065263A (en) | 1976-04-02 | 1977-12-27 | Woodbridge Iii Richard G | Analytical test strip apparatus |
DE3643516A1 (en) | 1986-12-19 | 1988-06-30 | Boehringer Mannheim Gmbh | TEST CARRIER FOR THE ANALYTICAL DETERMINATION OF INGREDIENTS OF BODY LIQUIDS |
US5419870A (en) * | 1987-01-27 | 1995-05-30 | V-Tech, Inc. | Antibody testing system |
ES2034186T3 (en) | 1987-02-17 | 1993-04-01 | Cmb Foodcan Plc | ANALYTICAL TESTING DEVICE. |
US5047206A (en) | 1987-03-11 | 1991-09-10 | Wayne State University | Reagent test strip |
US4810470A (en) * | 1987-06-19 | 1989-03-07 | Miles Inc. | Volume independent diagnostic device |
US5275785A (en) * | 1987-10-30 | 1994-01-04 | Unilever Patent Holdings B.V. | Test device for detecting an analyte in a liquid sample |
US5104813A (en) * | 1989-04-13 | 1992-04-14 | Biotrack, Inc. | Dilution and mixing cartridge |
US5820826A (en) | 1992-09-03 | 1998-10-13 | Boehringer Mannheim Company | Casing means for analytical test apparatus |
FI92882C (en) * | 1992-12-29 | 1995-01-10 | Medix Biochemica Ab Oy | Disposable test strip and process for its manufacture |
US5725774A (en) | 1995-04-07 | 1998-03-10 | Lxn Corp. | Whole blood separation method and devices using the same |
US6656741B1 (en) | 1999-03-03 | 2003-12-02 | Diabetes Diagnostics, Inc. | Air gap for controlling sample absorption and hematocrit dependence |
-
1999
- 1999-03-03 US US09/261,707 patent/US6656741B1/en not_active Expired - Lifetime
-
2000
- 2000-03-02 AU AU38636/00A patent/AU3863600A/en not_active Abandoned
- 2000-03-02 WO PCT/US2000/005509 patent/WO2000052468A1/en active IP Right Grant
- 2000-03-02 AT AT00917704T patent/ATE307337T1/en active
- 2000-03-02 DE DE60023270T patent/DE60023270T2/en not_active Expired - Lifetime
- 2000-03-02 DK DK00917704T patent/DK1159613T3/en active
- 2000-03-02 EP EP00917704A patent/EP1159613B1/en not_active Expired - Lifetime
- 2000-03-02 ES ES00917704T patent/ES2251368T3/en not_active Expired - Lifetime
-
2002
- 2002-06-05 HK HK02104286.3A patent/HK1042943B/en not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0215419A2 (en) * | 1985-09-18 | 1987-03-25 | Miles Inc. | Volume metering capillary gap device for applying a liquid sample onto a reactive surface |
US5470752A (en) * | 1994-06-29 | 1995-11-28 | Lxn Corporation | Multi-layer devices and methods of assaying for fructosamine |
US5597532A (en) * | 1994-10-20 | 1997-01-28 | Connolly; James | Apparatus for determining substances contained in a body fluid |
US5695949A (en) * | 1995-04-07 | 1997-12-09 | Lxn Corp. | Combined assay for current glucose level and intermediate or long-term glycemic control |
US6024919A (en) * | 1998-01-14 | 2000-02-15 | Lxn Corporation | Sonic treatment to selectively reduce the void volume of sintered polymers |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6656741B1 (en) | 1999-03-03 | 2003-12-02 | Diabetes Diagnostics, Inc. | Air gap for controlling sample absorption and hematocrit dependence |
Also Published As
Publication number | Publication date |
---|---|
DE60023270T2 (en) | 2006-05-24 |
EP1159613A1 (en) | 2001-12-05 |
DK1159613T3 (en) | 2005-12-19 |
ATE307337T1 (en) | 2005-11-15 |
US6656741B1 (en) | 2003-12-02 |
EP1159613B1 (en) | 2005-10-19 |
ES2251368T3 (en) | 2006-05-01 |
HK1042943A1 (en) | 2002-08-30 |
HK1042943B (en) | 2006-01-06 |
AU3863600A (en) | 2000-09-21 |
DE60023270D1 (en) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6555061B1 (en) | Multi-layer reagent test strip | |
EP0654659B1 (en) | Defined volume test device | |
EP0800082B1 (en) | Reagent test strip for blood glucose determination | |
EP0799896B1 (en) | Reagent test strip for determination of blood glucose | |
AU722471B2 (en) | Blood glucose strip having reduced sensitivity to hematocrit | |
KR970003312B1 (en) | Minimum procedure system for the determination of analysis | |
US20040265941A1 (en) | Combined assay for current glucose level and intermediate or long-term glycemic control | |
WO2003106968A2 (en) | Test strip for detection of analyte and methods of use | |
MXPA97002503A (en) | Reagent test stress to determine glucose in the san | |
EP0371513B1 (en) | Device and method for assay of liquid sample | |
JP2002510392A (en) | Analyte measuring device in body fluid | |
EP0767909B1 (en) | Multi-layer test devices and methods of assaying for fructosamine | |
US20040219691A1 (en) | Test strip with clear base support layer for visual perception of a liquid sample during application | |
EP1159613B1 (en) | Method and apparatus for controlling the adsorption of a liquid sample through an absorbent layer | |
JPH09105750A (en) | Measuring method corrected in hematocrit value | |
JP4626938B2 (en) | Test tool and measuring method | |
AU670882B2 (en) | Analyte detection device and process | |
CN115950868A (en) | Testing device and testing method for determining glycated albumin by antibody-spot method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000917704 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000917704 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09914684 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000917704 Country of ref document: EP |